Literature DB >> 3102869

Hunter's syndrome: a study in airway obstruction.

C T Sasaki, R Ruiz, R Gaito, J A Kirchner, B Seshi.   

Abstract

Hunter's disease is a genetically transmitted defect known to produce mucopolysaccharide infiltration of multiple organ systems. Upper airway obstruction is caused by an enlarged tongue, deformed pharynx, and short, thick neck. Its eventual lethal outcome by the second decade of life is known to result from an infiltrative cardiomyopathy leading to irreversible heart failure. Instead, our recent experience in the care of five patients with this disorder suggests the lethal event is related to progressive obstruction sequentially involving the upper, mid, and lower airway characterized by gradual deformation and collapse of the trachea. Autopsy and histopathologic whole organ sections demonstrate anteroposterior flattening of the trachea and bronchi with submucosal thickening producing structural alterations known only to this disease.

Entities:  

Mesh:

Year:  1987        PMID: 3102869

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  6 in total

1.  Successful noninvasive ventilation and enzyme replacement therapy in an adult patient with morbus hunter.

Authors:  M Westhoff; P Litterst
Journal:  JIMD Rep       Date:  2011-12-16

2.  Report of a Large Brazilian Family With a Very Attenuated Form of Hunter Syndrome (MPS II).

Authors:  C R D C Quaio; H Grinberg; M L C Vieira; A C Paula; G N Leal; I Gomy; S Leistner-Segal; R Giugliani; D R Bertola; C A Kim
Journal:  JIMD Rep       Date:  2011-11-08

Review 3.  Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy.

Authors:  J Edmond Wraith; Maurizio Scarpa; Michael Beck; Olaf A Bodamer; Linda De Meirleir; Nathalie Guffon; Allan Meldgaard Lund; Gunilla Malm; Ans T Van der Ploeg; Jiri Zeman
Journal:  Eur J Pediatr       Date:  2007-11-23       Impact factor: 3.183

4.  Double Valve Replacement in a Patient With Hunter Syndrome.

Authors:  Suresh Keshavamurthy; Andra Duncan; Akshay Kumar; Carlos Trombetta; Rene Rodriguez; Carmela Tan; Eric Roselli
Journal:  Cureus       Date:  2022-09-08

5.  Severe tracheal and bronchial collapse in adults with type II mucopolysaccharidosis.

Authors:  M Rutten; P Ciet; R van den Biggelaar; E Oussoren; J G Langendonk; A T van der Ploeg; M Langeveld
Journal:  Orphanet J Rare Dis       Date:  2016-04-26       Impact factor: 4.123

6.  Presentation and Treatments for Mucopolysaccharidosis Type II (MPS II; Hunter Syndrome).

Authors:  Molly Stapleton; Francyne Kubaski; Robert W Mason; Hiromasa Yabe; Yasuyuki Suzuki; Kenji E Orii; Tadao Orii; Shunji Tomatsu
Journal:  Expert Opin Orphan Drugs       Date:  2017-03-08       Impact factor: 0.694

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.